Tear film mucosal layer

The tear film mucosal layer is not a single molecule or canonical therapeutic target but rather refers to one component of the multilayered tear film that covers and protects the ocular surface. The traditional model describes three layers within the tear film: 1. Lipid Layer – Outermost, secreted by meibomian glands; reduces evaporation. 2. Aqueous Layer – Middle, produced by lacrimal glands; provides hydration and nutrients. 3. Mucous/Mucosal Layer – Innermost, composed primarily of gel-forming mucins such as MUC5AC from conjunctival goblet cells and membrane-associated mucins on epithelial surfaces. The mucosal or mucin layer serves several critical functions including hydrating the corneal epithelium, acting as an anti-pathogen barrier through its glycoprotein content, maintaining lubrication between eyelid and globe during blinking, stabilizing the overall tear structure for clear vision by smoothing micro-irregularities on the corneal epithelium’s surface[1][2][3]. Disruption in this layer’s composition—such as reduced goblet cell density or altered expression/splicing variants of key mucins like MUC1/MUC5AC—is implicated in dry eye syndromes and other ocular surface diseases[2]. Because it is an anatomical/structural feature made up of multiple molecules rather than a discrete protein/receptor/enzyme/transporter/gene product typically considered “druggable,” it is not classified as a canonical therapeutic target. Instead, therapies may aim to supplement its function indirectly via artificial tears containing lubricants/mimetic polymers or agents that stimulate natural secretion. In summary: “Tear film/mucosal layer” does not refer to an individual molecular entity suitable for structured pharmacological targeting but instead denotes part of an essential physiological barrier system at the front line between environment and ocular tissue integrity[1][2][3].

Other names

Tear filmMucous layer of tear filmPrecorneal tear film mucin layerOcular surface mucosal layer